Organisation/Company: Instituto de Investigación Sanitaria Puerta de Hierro – Segovia de Arana (IDIPHISA)
Department: Inmunology
Research Field: Medical sciences » Other
Researcher Profile: First Stage Researcher (R1)
Positions: Master Positions
Country: Spain
Application Deadline: 10 Apr 2025 - 15:00 (Europe/Madrid)
Type of Contract: Temporary
Job Status: Part-time
Hours Per Week: 24.30
Offer Starting Date: 27 Mar 2025
Is the job funded through the EU Research Framework Programme?
European Union / Next Generation EU
Reference Number: 2025-13
Is the Job related to staff position within a Research Infrastructure?
No
The Foundation for Biomedical Research of the Puerta de Hierro University Hospital is the managing body of the Research Institute of the Puerta de Hierro University Hospital, IDIPHISA. Being part of IDIPHISA means having the opportunity to develop biomedical research activities under conditions of quality and excellence, in the field of clinical and translational research, at a national and international level.
Currently, IDIPHISA has 5 research areas and 43 research groups.
The Foundation for Biomedical Research of the Puerta de Hierro University Hospital is calling for a researcher position, with the professional category of Higher Graduate of Professional Group II for Scientific-Technical Area 2.
The Molecular Immunology research group is made up of four researchers, is mainly focused on the development of recombinant antibodies for cancer immunotherapy and has published more than 50 related articles.
This contract is carried out under the aid/project "4-1BB costimulation conditioned by immune checkpoint for effective and safe cancer immunotherapy EFFESO", which is funded by the State Research Agency with file number CPP2022-009765.
Where to apply: E-mail ******
Medical sciences » Medicine
Master Degree or equivalent
The duration of the tasks to be carried out is expected to be approximately 22 months. The duration of the contract is subject to:
The salary remuneration is €18,055 gross per year, as established in the Collective Agreement of the Group of Companies of the Biomedical Research Foundations of the II.SS. of Sermas.
The dedication will be 64.